Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T12:11:21.295Z.
Consensus retrieved: unavailable. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T12:11:21.295Z.
Quote observation: 2026-10-05T17:49:36.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 015f4768d679608bc4b6bcfba81ca244afda57a14a617ca6285ea64adc9468bc
FORWARD PE RATIO
N/A
Drugs Made In America Acquisition Corp. Ordinary Shares
Market Cap
$264.62M
Forward PE Ratio
N/A
Market Cap
$262.30M
Forward PE Ratio
N/A
Market Cap
$261.73M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) | $264.62M | N/A |
| Thunder Bridge Capital Partners V L (TBCVU)vs › | $266.32M | N/A |
| Cantor Equity Partners V, Inc. Class A Ordinary Shares (CEPV)vs › | $262.30M | N/A |
| AMR Resources Acquisition Corp Class A Ordinary Shares (AMAC)vs › | $261.73M | N/A |
| Art Technology Acquisition Corp. (ARTC)vs › | $261.51M | N/A |
| GigCapital8 Corp. (GIW)vs › | $261.19M | N/A |
| FACT II Acquisition Corp (FACT)vs › | $260.97M | N/A |
| Cartesian Growth Corp. Iv (CGCF)vs › | $269.77M | N/A |
| Freedom Metals Acquisition Corp. (FDMM)vs › | $270.60M | N/A |
| First National Corporation (FXNC)vs › | $270.87M | 12.29 |
Trailing P/E
55.5
reported TTM EPS
Forward P/E
N/A
consensus fiscal-year EPS
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
